Cargando...
D-sorbitol can keep the viscosity of dispersive ophthalmic viscosurgical device at room temperature for long term
The combination of 3% sodium hyaluronate (HA) and 4% sodium chondroitin sulfate (CS) is used as a dispersive ophthalmic viscosurgical device (OVD) during cataract surgery. For most OVDs containing HA, storage at 2–8 °C is recommended to preserve product characteristics. In order to develop a dispers...
Gardado en:
| Publicado en: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group UK
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6856377/ https://ncbi.nlm.nih.gov/pubmed/31727999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-53390-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|